Tele-diabetes remote monitoring for kids with type 1 diabetes

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The trial assesses whether a tele-diabetes remote monitoring system can improve glycemic control and quality of life for pediatric and adolescent patients with type 1 diabetes. Participants use a Dexcom CGM and a closed-loop insulin pump, with WhatsApp-based notifications guiding care. The study compares an intervention group receiving alerts to a control group to see effects on time in range, hypoglycemia/hyperglycemia, HbA1c, adherence, healthcare utilization, and costs. Outcomes include ER visits for DKA or severe hypoglycemia, hospitalizations, and overall medical costs. The study is conducted at Sheba Medical Center and evaluates feasibility and effectiveness of this mHealth approach in this population.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Participants must have a confirmed diagnosis of Type 1 Diabetes Mellitus (T1DM).
* Participants must use Dexcome Continuous Glucose Monitoring (CGM)
* Must have access to a smartphone capable of receiving WhatsApp messages.
* Participants must use a closed-loop insulin pump system (also known as an artificial pancreas system) omnipod DIY or Tandem.

Exclusion Criteria:

* Participants who are not using Dexcome Continuous Glucose Monitoring (CGM) and a closed-loop insulin pump system

Where it's running

• Sheba medical center
  Ramat Gan, Israel Recruiting

Study contacts

• Study coordinator: Noah Gruber, MD
• Email: noah.gruber@sheba.health.gov.il
• Phone: +97235305015

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Outpatient Cardiac Telerehabilitation for Ischemic Heart Disease

  This study tests whether an outpatient cardiac telerehabilitation program can be as safe and effective as conventional rehab for people with ischemic heart disease.

  Recruiting Lithuanian University of Health Sciences · Kulautuva · NCT07927829

• RIGHTEST iFree 2 CGM in Pregnant Women With Diabetes

  This study tests the accuracy and safety of the RIGHTEST iFree 2 continuous glucose monitor in pregnant adults with type 1, type 2, or gestational diabetes.

  Recruiting Bionime Corporation · Ulm, Baden-Wurttemberg · NCT07889388

• emPath platform pilot to link and keep adults with opioid use disorder in care in Durham

  This pilot tests a mobile app and telemedicine approach to help adults with opioid use disorder start and stay in MOUD through community outreach in Durham, NC.

  Recruiting Duke University · Durham, North Carolina · NCT07810322

• Integrated Mobile Health Platform for Early Detection in Critical Illness

  This study tests whether an integrated mobile health platform can help detect early clinical changes in adults with critical illness who are in the ICU.

  Recruiting Sohag University · Sohag, Sohag Governorate · NCT07773675

• Helping Latino teens and young adults try the Medtronic 780G insulin pump in Spanish and English

  A culturally and linguistically tailored onboarding program helps Latino/Hispanic youth with type 1 diabetes start and keep using the Medtronic MiniMed 780G system.

  Recruiting University of Colorado, Denver · Aurora, Colorado · NCT07720388

• Health Ahead: Comparing AI vs. Humans for Preventive Health Screening

  This study tests AI-assisted screening interpretation against human-only reads to see if automated screening can match or improve current practice for adults, especially in underserved areas.

  Recruiting Longevity Metrics, Inc. · Boulder, Colorado · NCT07669168

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.